News for AstraZeneca plc (ADR)

BRIEF-AstraZeneca files nasal flu vaccine in Europe
Forbes - 21 hours ago
* MedImmune, the global biologics unit of AstraZeneca (nyse: AZN - news - people ), announced today that it has submitte...

AstraZeneca spent more than $1.3M lobbying in 3Q
Forbes - 12 hours ago
AP , 01.05.09, 09:13 AM EST British drugmaker AstraZeneca PLC spent more than $1.3 million in the third quarter lobbying th...

Micromet Key Events for 2009
Reuters - 14 hours ago
Key Presentations and Milestones Expected for 2009 BETHESDA, Md., Jan. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmac...

FACTBOX-FTSE 100 winners, losers in 2008
Reuters - 27 minutes ago
Dec 31 (Reuters) - Britain's FTSE 100 .FTSE tumbled 31 percent in 2008, the largest annual drop since its launch in 1984, as a c...

Seven Summits Research Releases Comments on HAL, MOS, DOW, AZN, and NSANY
PR Newswire (press release) - Dec 29, 2008
http://www.go7now.com/nb/1229X (Note: You may have to copy this link into you...

FACTBOX-Job cuts mount as global downturn bites
Reuters - 2 hours ago
Dec 29 (Reuters) - As many as 600,000 people in Britain could lose their jobs next year, making 2009 the worst year for unem...

AstraZeneca (AZN) NewsBite - AZN Rises on Unusual Volume
Market Intelligence Center - 11 minutes ago
AstraZeneca (NYSE: AZN) opened at $40.34. So far today, the stock has hit a low of $40.18 and...

Seven Summits Research Releases Comments on HAL, MOS, DOW, AZN, and NSANY
Stockhouse - 4 minutes ago
http://www.go7now.com/nb/1229X (Note: You may have to copy this link into your browser then p...

BridgewaterEquity.com Free Fundamental Sector & Market Research on AZN, AXP, SCG and ANPI
Market Wire (press release) - Dec 24, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being...

Daily Mail, London, market report column
Therapeutics Daily (Registration) (press release) - 16 hours ago
Dec. 26--DEPRESSIVE NEWS FOR ASTRAZENECA: Astrazeneca's boss David Brennan had his Chris...